Order Article Reprints

Colombatto P, Demirtas CO, Ricco G, Civitano L, Boraschi P, Scalise P, Cavallone D, Oliveri F, Romagnoli V, Bleve P, et al. Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers. 2021; 13(9):2064. https://doi.org/10.3390/cancers13092064

Colombatto, Piero, Coskun Ozer Demirtas, Gabriele Ricco, Luigi Civitano, Piero Boraschi, Paola Scalise, Daniela Cavallone, Filippo Oliveri, Veronica Romagnoli, Patrizia Bleve, and et al. 2021. "Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib" Cancers 13, no. 9: 2064. https://doi.org/10.3390/cancers13092064

Colombatto, P., Demirtas, C. O., Ricco, G., Civitano, L., Boraschi, P., Scalise, P., Cavallone, D., Oliveri, F., Romagnoli, V., Bleve, P., Coco, B., Salvati, A., Urbani, L., Bonino, F., & Brunetto, M. R. (2021). Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers, 13(9), 2064. https://doi.org/10.3390/cancers13092064